Duriye Damla Sevgi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Duriye Damla Sevgi has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Justis P. Ehlers
The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cleveland Clinic, Cleveland, OH 44195, USA
6 shared publications - Lucia Sobrin
Department of Ophthalmology, Mass Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA
6 shared publications Samaneh Davoudi
Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA USA
5 shared publicationsEvangelia Papavasilieou
Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA USA
3 shared publicationsRamak Roohipoor
Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA USA
3 shared publicationsCagla Yasa
Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA USA
2 shared publications
Latest Publications
- 22 May 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (10) , 917
Presumed Ocular Histoplasmosis with Choroidal Neovascularization in a 4-year-old
- 22 May 2023
- Published by Elsevier in Ophthalmology Retina
- Vol. 7 (10) , 917
Presumed Ocular Histoplasmosis with Choroidal Neovascularization in a 4-year-old
- Open Access
- 10 April 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (4) , 608
Predictive Assessment of Quantitative Ultra-Widefield Angiographic Features for Future Need for Anti-VEGF Therapy in Diabetic Eye Disease
The objective of this study was to identify biomarkers that predict a future need for anti-VEGF therapy in diabetic retinopathy (DR). Eyes with DR that underwent ultra-widefield angiography (UWFA) and had at least a 1 year follow-up were grouped based on future anti-VEGF treatment requirements: (1) not requiring treatment, (2) immediate treatment (within 3 months of UWFA), and (3) delayed treatment (after 3 months of UWFA). Quantitative UWFA features and clinical factors were evaluated. Random forest models were built to differentiate eyes requiring immediate and delayed treatment from the eyes not requiring treatment. A total of 173 eyes were included. The mean follow-up was 22 (range: 11–43) months. The macular leakage index, panretinal leakage index, presence of DME, and visual acuity were significantly different in eyes requiring immediate (n = 38) and delayed (n = 34) treatment compared to eyes not requiring treatment (n = 101). Random forest model differentiating eyes requiring immediate treatment from eyes not requiring treatment demonstrated an AUC of 0.91 ± 0.07. Quantitative angiographic features have potential as important predictive biomarkers of a future need for anti-VEGF therapy in DR and may serve to guide the frequency of a follow-up.
- 10 April 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (4) , 608
Open AccessPredictive Assessment of Quantitative Ultra-Widefield Angiographic Features for Future Need for Anti-VEGF Therapy in Diabetic Eye Disease
The objective of this study was to identify biomarkers that predict a future need for anti-VEGF therapy in diabetic retinopathy (DR). Eyes with DR that underwent ultra-widefield angiography (UWFA) and had at least a 1 year follow-up were grouped based on future anti-VEGF treatment requirements: (1) not requiring treatment, (2) immediate treatment (within 3 months of UWFA), and (3) delayed treatment (after 3 months of UWFA). Quantitative UWFA features and clinical factors were evaluated. Random forest models were built to differentiate eyes requiring immediate and delayed treatment from the eyes not requiring treatment. A total of 173 eyes were included. The mean follow-up was 22 (range: 11–43) months. The macular leakage index, panretinal leakage index, presence of DME, and visual acuity were significantly different in eyes requiring immediate (n = 38) and delayed (n = 34) treatment compared to eyes not requiring treatment (n = 101). Random forest model differentiating eyes requiring immediate treatment from eyes not requiring treatment demonstrated an AUC of 0.91 ± 0.07. Quantitative angiographic features have potential as important predictive biomarkers of a future need for anti-VEGF therapy in DR and may serve to guide the frequency of a follow-up.
- Open Access
- 8 November 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (11) , 1161
Quantitative Imaging Biomarkers in Age-Related Macular Degeneration and Diabetic Eye Disease: A Step Closer to Precision Medicine
The management of retinal diseases relies heavily on digital imaging data, including optical coherence tomography (OCT) and fluorescein angiography (FA). Targeted feature extraction and the objective quantification of features provide important opportunities in biomarker discovery, disease burden assessment, and predicting treatment response. Additional important advantages include increased objectivity in interpretation, longitudinal tracking, and ability to incorporate computational models to create automated diagnostic and clinical decision support systems. Advances in computational technology, including deep learning and radiomics, open new doors for developing an imaging phenotype that may provide in-depth personalized disease characterization and enhance opportunities in precision medicine. In this review, we summarize current quantitative and radiomic imaging biomarkers described in the literature for age-related macular degeneration and diabetic eye disease using imaging modalities such as OCT, FA, and OCT angiography (OCTA). Various approaches used to identify and extract these biomarkers that utilize artificial intelligence and deep learning are also summarized in this review. These quantifiable biomarkers and automated approaches have unleashed new frontiers of personalized medicine where treatments are tailored, based on patient-specific longitudinally trackable biomarkers, and response monitoring can be achieved with a high degree of accuracy.
- 8 November 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (11) , 1161
Open AccessQuantitative Imaging Biomarkers in Age-Related Macular Degeneration and Diabetic Eye Disease: A Step Closer to Precision Medicine
The management of retinal diseases relies heavily on digital imaging data, including optical coherence tomography (OCT) and fluorescein angiography (FA). Targeted feature extraction and the objective quantification of features provide important opportunities in biomarker discovery, disease burden assessment, and predicting treatment response. Additional important advantages include increased objectivity in interpretation, longitudinal tracking, and ability to incorporate computational models to create automated diagnostic and clinical decision support systems. Advances in computational technology, including deep learning and radiomics, open new doors for developing an imaging phenotype that may provide in-depth personalized disease characterization and enhance opportunities in precision medicine. In this review, we summarize current quantitative and radiomic imaging biomarkers described in the literature for age-related macular degeneration and diabetic eye disease using imaging modalities such as OCT, FA, and OCT angiography (OCTA). Various approaches used to identify and extract these biomarkers that utilize artificial intelligence and deep learning are also summarized in this review. These quantifiable biomarkers and automated approaches have unleashed new frontiers of personalized medicine where treatments are tailored, based on patient-specific longitudinally trackable biomarkers, and response monitoring can be achieved with a high degree of accuracy.
- 1 June 2021
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 226, 126-136
Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes
- 1 June 2021
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 226, 126-136
Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes
- 28 November 2020
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 224, 217-227
Retinal Fluid Volatility Associated With Interval Tolerance and Visual Outcomes in Diabetic Macular Edema in the VISTA Phase III Trial
- 28 November 2020
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 224, 217-227
Retinal Fluid Volatility Associated With Interval Tolerance and Visual Outcomes in Diabetic Macular Edema in the VISTA Phase III Trial
- 31 October 2020
- Published by BMJ in British Journal of Ophthalmology
- Vol. 106 (2) , 251-255
Longitudinal assessment of quantitative ultra-widefield ischaemic and vascular parameters in sickle cell retinopathy
Purpose To evaluate longitudinal quantitative ischaemic and vasculature parameters, including ischaemic index, vessel area, length and geodesic distance in sickle cell retinopathy (SCR) on ultra-widefield fluorescein angiography (UWFA). Methods Optimal UWFA images from two longitudinal timepoints of 74 eyes from 45 patients with SCR were aligned and a common region of interest was determined. A deep-learning augmented ischaemia and vascular segmentation platform was used for feature extraction. Geodesic distance maps demonstrating the shortest distance within the vascular masks from the centre of the optic disc were created. Ischaemic index, vessel area, vessel length and geodesic distance were measured. Paired t-test and linear mixed effect model analysis were performed. Results Overall, 25 (44 eyes) patients with HbSS, 14 (19 eyes) with HbSC, 6 (11 eyes) with HbSthal and other genotypes were included. Mean age was 40.1±11.0 years. Mean time interval between two UWFA studies was 23.0±15.1 months (range: 3–71.3). Mean panretinal ischaemic index increased from 10.0±7.2% to 10.9±7.3% (pConclusion Longitudinal ischaemic index and retinal vascular parameter measurements demonstrate statistically significant progression in SCR. The clinical significance of these relatively small magnitude changes remains unclear but may provide insights into the progression of retinal ischaemia in SCR.
- 31 October 2020
- Published by BMJ in British Journal of Ophthalmology
- Vol. 106 (2) , 251-255
Longitudinal assessment of quantitative ultra-widefield ischaemic and vascular parameters in sickle cell retinopathy
Purpose To evaluate longitudinal quantitative ischaemic and vasculature parameters, including ischaemic index, vessel area, length and geodesic distance in sickle cell retinopathy (SCR) on ultra-widefield fluorescein angiography (UWFA). Methods Optimal UWFA images from two longitudinal timepoints of 74 eyes from 45 patients with SCR were aligned and a common region of interest was determined. A deep-learning augmented ischaemia and vascular segmentation platform was used for feature extraction. Geodesic distance maps demonstrating the shortest distance within the vascular masks from the centre of the optic disc were created. Ischaemic index, vessel area, vessel length and geodesic distance were measured. Paired t-test and linear mixed effect model analysis were performed. Results Overall, 25 (44 eyes) patients with HbSS, 14 (19 eyes) with HbSC, 6 (11 eyes) with HbSthal and other genotypes were included. Mean age was 40.1±11.0 years. Mean time interval between two UWFA studies was 23.0±15.1 months (range: 3–71.3). Mean panretinal ischaemic index increased from 10.0±7.2% to 10.9±7.3% (pConclusion Longitudinal ischaemic index and retinal vascular parameter measurements demonstrate statistically significant progression in SCR. The clinical significance of these relatively small magnitude changes remains unclear but may provide insights into the progression of retinal ischaemia in SCR.
- 19 August 2020
- Published by BMJ in British Journal of Ophthalmology
- Vol. 105 (8) , 1155-1160
Radiomics-based assessment of ultra-widefield leakage patterns and vessel network architecture in the PERMEATE study: insights into treatment durability
Aim To evaluate the potential of radiomics-based ultra-widefield fluorescein angiography (UWFA)-derived imaging biomarkers in retinal vascular disease for predicting therapeutic durability of intravitreal aflibercept injection (IAI). Methods The Peripheral and Macular Retinal Vascular Perfusion and Leakage Dynamics in Diabetic Macular Edema and Retinal Venous Occlusions During Intravitreal Aflibercept Injection (IAI) Treatment for Retinal Edema (PERMEATE) study prospectively evaluated quantitative UWFA dynamics in diabetic macular oedema or macular oedema secondary to retinal vascular occlusion. 27 treatment-naïve eyes were treated with 2 mg IAI q4 weeks for the first 6 months, and then administered q8 weeks. Morphological and graph-based attributes were used to model the spatial distribution of leakage areas, while tortuosity measures were used to model the vessel network disorder. Eyes were grouped based on functional tolerance of the first 8-week treatment interval challenge. ‘Non-rebounders’ (N=15) maintained/improved best-corrected visual acuity (BCVA) following the 8-week challenge. ‘Rebounders’ (N=12) exhibited worsened BVCA. The image biomarkers were used with a machine learning classifier to preliminarily evaluate their ability to predict BCVA stability. Results Two new UWFA image-derived biomarkers were identified and extracted. The cross-validated area under the receiver operating characteristic curve (AUC) was 0.77±0.14 using baseline leakage distribution features and 0.73±0.10 for the UWFA baseline tortuosity measures. Additionally, the change in vascular tortuosity between month 4 and baseline yielded an AUC of 0.73±0.08. Three baseline clinical features of letter score, macular volume and central subfield thickness yielded a corresponding AUC of 0.42±0.09. Conclusions Two computer-extracted UWFA radiomics-based descriptors were identified as potential biomarkers for predicting treatment durability and tolerance of longer treatment intervals. Conventional treatment parameters were not significantly different between these same groups.
- 19 August 2020
- Published by BMJ in British Journal of Ophthalmology
- Vol. 105 (8) , 1155-1160
Radiomics-based assessment of ultra-widefield leakage patterns and vessel network architecture in the PERMEATE study: insights into treatment durability
Aim To evaluate the potential of radiomics-based ultra-widefield fluorescein angiography (UWFA)-derived imaging biomarkers in retinal vascular disease for predicting therapeutic durability of intravitreal aflibercept injection (IAI). Methods The Peripheral and Macular Retinal Vascular Perfusion and Leakage Dynamics in Diabetic Macular Edema and Retinal Venous Occlusions During Intravitreal Aflibercept Injection (IAI) Treatment for Retinal Edema (PERMEATE) study prospectively evaluated quantitative UWFA dynamics in diabetic macular oedema or macular oedema secondary to retinal vascular occlusion. 27 treatment-naïve eyes were treated with 2 mg IAI q4 weeks for the first 6 months, and then administered q8 weeks. Morphological and graph-based attributes were used to model the spatial distribution of leakage areas, while tortuosity measures were used to model the vessel network disorder. Eyes were grouped based on functional tolerance of the first 8-week treatment interval challenge. ‘Non-rebounders’ (N=15) maintained/improved best-corrected visual acuity (BCVA) following the 8-week challenge. ‘Rebounders’ (N=12) exhibited worsened BVCA. The image biomarkers were used with a machine learning classifier to preliminarily evaluate their ability to predict BCVA stability. Results Two new UWFA image-derived biomarkers were identified and extracted. The cross-validated area under the receiver operating characteristic curve (AUC) was 0.77±0.14 using baseline leakage distribution features and 0.73±0.10 for the UWFA baseline tortuosity measures. Additionally, the change in vascular tortuosity between month 4 and baseline yielded an AUC of 0.73±0.08. Three baseline clinical features of letter score, macular volume and central subfield thickness yielded a corresponding AUC of 0.42±0.09. Conclusions Two computer-extracted UWFA radiomics-based descriptors were identified as potential biomarkers for predicting treatment durability and tolerance of longer treatment intervals. Conventional treatment parameters were not significantly different between these same groups.
- 1 April 2020
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 24 (2) , 99.e1-99.e6
Contractile morning glory disk anomaly: analysis of the cyclic contractions and literature review
- 1 April 2020
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 24 (2) , 99.e1-99.e6
Contractile morning glory disk anomaly: analysis of the cyclic contractions and literature review
- 16 March 2020
- Published by SPIE-Intl Soc Optical Eng
- Vol. 11319, 27
3D ultrasound biomicroscopy (3D-UBM) imaging of the eye for unique 3D assessment of ciliary body
We developed a methodology for 3D assessment of ciliary body of the eye, an important, but understudied tissue, using our new 3D ultrasound biomicroscopy (3D-UBM) imaging system. The ciliary body produces aqueous humor, which if not drained properly, can lead to increased intraocular pressure and glaucoma, a leading cause of blindness. Most medications and some surgical procedures for glaucoma target the ciliary body. Ciliary body is also responsible for focusing-accommodation by muscle contraction and relaxation. UBM is the only imaging modality which can be used to visualize structures behind the opaque iris, such as ciliary body. Our 3D-UBM acquires several hundred high resolutions (50 MHz) 2D-UBM images and creates a 3D volume, enabling heretofore unavailable en face visualizations and quantifications. In this study, we calculated unique 3D biometrics from automated segmentation using deep learning (UNet). Our results show accuracy of 0.93 ± 0.01, sensitivity of 0.79 ± 0.07 and dice score of 0.72 ± 0.07 on deep learning segmentation of ciliary muscle. For an eye, volume of ciliary body was 67.87 mm3, single ciliary process volumes were 0.234 ± 0.093 mm3 with surface areas adjacent to aqueous humor of 3.02 ± 1.07 mm2. Automated and manual measurements of ciliary muscle volume and cross-sectional area are compared which show overestimation in volume measurement but higher agreeability in cross-sectional area measurements.
- 16 March 2020
- Published by SPIE-Intl Soc Optical Eng
- Vol. 11319, 27
3D ultrasound biomicroscopy (3D-UBM) imaging of the eye for unique 3D assessment of ciliary body
We developed a methodology for 3D assessment of ciliary body of the eye, an important, but understudied tissue, using our new 3D ultrasound biomicroscopy (3D-UBM) imaging system. The ciliary body produces aqueous humor, which if not drained properly, can lead to increased intraocular pressure and glaucoma, a leading cause of blindness. Most medications and some surgical procedures for glaucoma target the ciliary body. Ciliary body is also responsible for focusing-accommodation by muscle contraction and relaxation. UBM is the only imaging modality which can be used to visualize structures behind the opaque iris, such as ciliary body. Our 3D-UBM acquires several hundred high resolutions (50 MHz) 2D-UBM images and creates a 3D volume, enabling heretofore unavailable en face visualizations and quantifications. In this study, we calculated unique 3D biometrics from automated segmentation using deep learning (UNet). Our results show accuracy of 0.93 ± 0.01, sensitivity of 0.79 ± 0.07 and dice score of 0.72 ± 0.07 on deep learning segmentation of ciliary muscle. For an eye, volume of ciliary body was 67.87 mm3, single ciliary process volumes were 0.234 ± 0.093 mm3 with surface areas adjacent to aqueous humor of 3.02 ± 1.07 mm2. Automated and manual measurements of ciliary muscle volume and cross-sectional area are compared which show overestimation in volume measurement but higher agreeability in cross-sectional area measurements.
- 4 January 2020
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (5) , 857-864
Comparison of Modified Posterior Sub-Tenon’s vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Purpose: To compare the safety and efficacy of trans-septal vs. modified posterior sub-Tenon’s (PST) corticosteroid injections for noninfectious uveitis. Methods: Retrospective comparison of periocular triamcinolone injection by modified PST (n = 36) vs. traditional trans-septal (n = 79) techniques. Safety and efficacy outcomes were analyzed with regression models. Results: There was no significant difference in visual acuity improvement between the groups at 6 months. There were higher rates of vitritis resolution in the modified PST group but this was not statistically significant (85.7% vs 62.9%, p = .07). Intraocular pressure (IOP) elevation rate trended higher with the modified PST injection (21.9% vs 9.0%, p = .06), with no instances of glaucoma surgery in either group. Two modified PST injection patients with refractory IOP rises had IOP normalization after corticosteroid depot removal. One year cataract surgery rates were similar. Conclusion: Modified PST injection offers clinical efficacy but with possibly higher IOP response rate which could be managed with corticosteroid removal.
- 4 January 2020
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (5) , 857-864
Comparison of Modified Posterior Sub-Tenon’s vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Purpose: To compare the safety and efficacy of trans-septal vs. modified posterior sub-Tenon’s (PST) corticosteroid injections for noninfectious uveitis. Methods: Retrospective comparison of periocular triamcinolone injection by modified PST (n = 36) vs. traditional trans-septal (n = 79) techniques. Safety and efficacy outcomes were analyzed with regression models. Results: There was no significant difference in visual acuity improvement between the groups at 6 months. There were higher rates of vitritis resolution in the modified PST group but this was not statistically significant (85.7% vs 62.9%, p = .07). Intraocular pressure (IOP) elevation rate trended higher with the modified PST injection (21.9% vs 9.0%, p = .06), with no instances of glaucoma surgery in either group. Two modified PST injection patients with refractory IOP rises had IOP normalization after corticosteroid depot removal. One year cataract surgery rates were similar. Conclusion: Modified PST injection offers clinical efficacy but with possibly higher IOP response rate which could be managed with corticosteroid removal.